GLP-1 use linked to £1bn cut in British grocery spending
Worldpanel data suggest British households with GLP-1 users spend over £1bn less on groceries, with 2.6 million adult users, 15% declines for crisps and alcohol, and 30% frozen-meal volume growth.

By Olivia Hart
British households that include a GLP-1 user spent an estimated £1bn ($1.31bn) less on groceries, according to research from Worldpanel by Numerator. The research also estimates that 2.6 million adults in Britain use the weight-loss medication.
The figure applies to spending by households with a user; it does not mean every product in those baskets fell by the same amount. Nor is it a reported reduction in retailer revenue or operating profit.
Worldpanel’s fourth study, conducted in August, covered more than 9,600 households. A June poll had estimated that GLP-1 users were spending £780m less on groceries, while the latest survey places the reduction above £1bn.
The June and August estimates differ by at least £220m. The published figures do not specify a measurement period for the £1bn, so operators should treat it as a research estimate rather than a booked revenue loss.
Chantel Kennaugh, head of public sector and nutrition at Worldpanel, said: “Too often, the GLP-1 impact is framed as a story about value or volume decline but there’s a much more interesting story sitting behind this. From a grocery perspective, this new audience is being more mindful about what and how they eat.”
Impulse and indulgence products took the biggest hit. Spending on crisps fell 15%, and expenditure on alcohol fell by the same 15%.
Those categories show the clearest spending effect in the British data. At the same time, volume sales of frozen ready meals jumped 30%, while unit sales of hot chocolate and malt drinks rose 16%.
The percentages do not measure the same thing. The 15% declines cover expenditure, while the 30% and 16% gains cover sales volume and units sold, so the figures require separate pricing and margin analysis.
The source provides no cost of goods, labor or gross-margin figures. A 15% spending decline therefore cannot be equated with a 15% profit decline, and unit growth does not by itself establish stronger profitability.
Some spending is moving outside food and drink. In the first year after starting the medication, GLP-1 users spent £78m more than expected on health and beauty products, Worldpanel said.
Worldpanel estimates that 8.5% of British households contain a GLP-1 user. It says that equals the number of vegetarians and pescatarians combined; the household share is roughly one in 12.
Kennaugh added: “Our estimates suggest that GLP-1 usage is set to surpass 10% of GB households in 2027. This is not a flash-in-the-pan trend but a seismic change that requires retailers and manufacturers to re-think their strategies.”
The projected threshold stands above Worldpanel’s current 8.5% estimate. For category buyers, it makes GLP-1 demand a planning factor for 2027 rather than a small, isolated adjustment.
What does this change for grocery operators?
The immediate change is a product-mix problem, not evidence that every grocery category is shrinking. British data point away from impulse and indulgence, while frozen ready meals and malt drinks gain volume; sourcing, shelf space and promotion will need to reflect that split.
Operators should separate price, volume and mix when planning. The released data do not fully isolate lower prices from lower quantities or substitution, and they do not show which category changes improve margins.
Across the Atlantic, Tesco-owned customer data firm Dunnhumby found wider household effects in the Americas. Its August survey covered 8,500 consumers across six countries and found that each GLP-1 user shaped the dietary habits of an average of 2.08 people within their household.
Dunnhumby did not provide a comparable grocery-spending reduction for those markets. It measured reach through medication use and reported dietary influence instead.
The six countries were the US, Canada, Mexico, Brazil, Colombia and Chile. Across them, 10.2% of adults said they had used a GLP-1 medication, while 21.3% said their food and drink choices were shaped by the drugs.
The latter measure is more than one in five adults, extending the reported influence beyond only the person taking the medication. That spillover matters for brands and retailers planning meals and promotions around household needs.
Taken together, the research makes GLP-1 adoption a planning variable for grocers and food manufacturers, not a niche dietary effect. Worldpanel’s projection that usage could surpass 10% of GB households in 2027 gives operators a concrete horizon for adjusting sourcing and promotional plans.
More from Olivia Hart
Show full bio
Staff writer covering regulation, policy and their impact on Restaurant and hotel operations at The Pass Brief.
757 articles


